Iacovos P Michael

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2021
Publications (10 Years): 4

Top Topics

Vascular Endothelial Growth Factor

Tyrosine Kinase

Neuroendocrine Tumors

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Journal of neurochemistry

Science translational medicine

Cancer discovery

École Polytechnique Fédérale de Lausanne

University of Toronto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

École Polytechnique Fédérale de Lausanne

Switzerland

Postdoctoral Fellow (Dr. D. Hanahan Laboratory) :: Swiss Institute for Experimental Cancer Research

Lunenfeld-Tanenbaum Research Institute

Canada

Postdoctoral Fellow (Dr. A. Nagy Laboratory)

Education History

University of Toronto

Canada

PHD :: Molecular Genetics

University of Toronto

Canada

MSC :: Laboratory Medicine & Pathobiology

University of Patras

Greece

BSC :: School of Pharmacy

Publications

Sadegh Saghafinia, Krisztian Homicsko, Annunziata Di Domenico, Stephan Wullschleger, Aurel Perren, Ilaria Marinoni, Giovanni Ciriello, Iacovos P Michael, Douglas Hanahan
Cancer Cells Retrace a Stepwise Differentiation Program during Malignant Progression. Cancer discovery 11 (10) (2021)
Vasia Samantha Sykioti, Mantia Karampetsou, Ioanna Chalatsa, Alexia Polissidis, Iacovos P Michael, Marina Pagaki-Skaliora, Andras Nagy, Evangelia Emmanouilidou, Georgia Sotiropoulou, Kostas Vekrelli S
Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a-synuclein in mouse brain. Journal of neurochemistry 157 (6) (2020)
Iacovos P Michael, Sadegh Saghafinia, Douglas Hanahan
A set of microRNAs coordinately controls tumorigenesis, invasion, and metastasis. Proceedings of the National Academy of Sciences of the United States of America 116 (48) (2019)
Elizabeth Allen, Arnaud Jabouille, Lee B Rivera, Inge Lodewijckx, Rindert Missiaen, Veronica Steri, Kevin Feyen, Jaime Tawney, Douglas Hanahan, Iacovos P Michael, Gabriele Bergers
Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Science translational medicine 9 (385) (2017)